GRIFOLS, S.A. «12345...» Página 3 de 20 desde 01/07/1988 hasta 19/09/2014 03/01/2014 15:37 GRIFOLS, S.A. Loans, credit lines and guarantees Subscription of a bridge loan which shall be destined to the acquisition of the diagnostics unit of Novartis International AG Número de registro: 198321 17/12/2013 13:14 GRIFOLS, S.A. Announcements and resolutions of general shareholders meetings Celebration of an Extraordinary General Shareholders’ Meeting and approval of all the proposals submitted to the shareholders’ consideration. Número de registro: 197043 20/11/2013 08:21 GRIFOLS, S.A. Others on corporate transactions Grifols, S.A. notifies the acquisition of 21.30% of the biotechnological company TiGenix N.V. Número de registro: 195449 15/11/2013 08:21 GRIFOLS, S.A. Announcements and resolutions of general shareholders meetings Call to the Extraordinary General Shareholders’ Meeting of Grifols, S.A. Número de registro: 195238 11/11/2013 07:21 GRIFOLS, S.A. Transmissions and purchases of capital undertakings Grifols, S.A. announces the signature, on 10 November 2013, of an agreement by which Grifols, S.A. acquires a diagnostic business unit of the Swiss company Novartis International AG for a total amount of US$ 1,675 billion (€ 1,240 billion). Número de registro: 195040 Relacionado con 198495 del 10/01/2014 (07:56) 05/11/2013 08:23 GRIFOLS, S.A. Interim financial information La sociedad remite información sobre los resultados del tercer trimestre de 2013 Número de registro: 194841 18/10/2013 08:39 GRIFOLS, S.A. Block trades UBS Limited comunica el resultado de la colocación de acciones de Grifols, S.A. representativas de un 2,72% de la totalidad de acciones de clase A. Número de registro: 194072 Relacionado con 194061 del 17/10/2013 (18:06) 17/10/2013 18:06 GRIFOLS, S.A. Block trades UBS Limited comunica el inicio de un proceso de colocación de acciones de Grifols, S.A. representativas de hasta un 2,72% de la totalidad de acciones de clase A, titularidad de Alken Asset Management LLP Número de registro: 194061 Relacionado con 194072 del 18/10/2013 (08:39) 18/09/2013 10:34 GRIFOLS, S.A. Others on business performance and financial information Grifols, S.A. informs the start of a clinical trial in phase I of the ABvac40 vaccine for patients with Alzheimer’s disease Número de registro: 192927 28/08/2013 08:48 GRIFOLS, S.A. Others on corporate transactions Grifols informs of the closing of the subscription of the shares of Aradigm Corporation Número de registro: 192203 Relacionado con 187674 del 21/05/2013 (08:25) Página 3 de 20 «12345...»